Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 1601 - 1608 of 11454 results
Chambers D&I North America Report 2022
September 22, 2022| News
Elimination of the Duty of Care In Delaware? Statutory Exculpation of Officers: Recent Amendment to Section 102(B)(7) of the Delaware General Corporation Law
September 21, 2022| Advisory| Viewpoint
How The America Invents Act Has Hurt SMEs
September 21, 2022| News
From the Edge - In the Boardroom: Session 3 - Board Committees
September 21, 2022| Podcast| Viewpoint
On Sharing and Managing Competitively Sensitive Information in M&A Transactions
September 20, 2022| Advisory| Viewpoint
Pharmaceutical Manufacturer Pays $7.9 Million to Resolve Allegations that it Caused the Submission of Over-the-Counter Drugs to Medicare Part D
September 20, 2022| Blog| Viewpoint
MintzTech Connect Industry News: Spotlight on Adgile Media Group
September 19, 2022| Article| Viewpoint
News & Press Releases
Venture Mega-Rounds Return to Biotech
September 26, 2024
Member Cheryl Reicin was quoted in WSJ Pro Venture Capital in an article about how venture mega rounds are becoming more frequent in the biotech industry. Specifically, Cheryl discusses the need for startups to be aware of the pressures and implications that may come from larger funding rounds.
Lenovo’s Setback in Ericsson ITC Case May Impact Other SEP Disputes
September 26, 2024
Intellectual Property Division Chair Michael Renaud was quoted by IAM in an article about the ITC case between Ericsson and Lenovo and its potential implications for FRAND negotiations. While most ITC cases involving Standard Essential Patents (SEPs) have resulted in no violation findings, this case could change that.
Mintz Ranked in 2025 Edition of Chambers Canada
September 26, 2024
Mintz announced that it has been ranked in the 2025 edition of Chambers Canada. The firm was rankedin both the Life Sciences and Cannabis Law categories. Six attorneys were also ranked in individual categories including Life Sciences, Private Equity, Investment Funds, Cannabis, and Pensions & Benefits.